"Immunizations in Solid-Organ Transplant Recipients"

Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.

 

------------------------------------------------------------

 

March 27, 2002

 

INTERNATIONAL IMMUNIZATION NEWS

 

"Immunizations in Solid-Organ Transplant Recipients"

Lancet (www.thelancet.com) (03/16/02) Vol. 359, No. 9310, P. 957; Stark, Klaus; G|nther, Matthias; Schonfeld, Christian

 

More than 600,000 solid-organ transplantations have been performed worldwide, and according to a review published in The Lancet, this number will continue to increase.  Improvements in surgical techniques and immunosuppressive treatments have resulted in an increase of survival rates approaching 70 percent to 90 percent. However, diseases such as hepatitis and influenza pose major health hazards for solid-organ transplant patients; vaccination is crucial to prevent infection, yet the increase of antibody levels in solid-organ transplantation patients might indicate successful vaccination, but not protection.  The immunosuppressive agents needed to force the body into accepting the new organ also open the body to many outside diseases normally kept away quite easily by the immune system.  To date, research on the vaccination of solid-organ transplantation patients is almost non-existent; thus, the authors hope to stimulate research in this area.

 

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.